| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.06 | 0.2 |